Panagiotakaki Eleni, Tzetis Maria, Manolaki Nina, Loudianos Giorgos, Papatheodorou Athanasios, Manesis Emmanuel, Nousia-Arvanitakis Sanda, Syriopoulou V, Kanavakis Emmanuel
Medical Genetics, Athens University, St. Sophia's Children's Hospital, Athens, Greece.
Am J Med Genet A. 2004 Dec 1;131(2):168-73. doi: 10.1002/ajmg.a.30345.
Wilson disease (WND) is caused by mutations in the ATP7B gene and exhibits substantial allelic heterogeneity. In this study we report the results of molecular analyses of 20 WND families not described previously. When combined with our prior results, the cohort includes 93 index patients from 69 unrelated families. Twenty different mutations accounted for 86% of the WND chromosomes. The most frequent were p.H1069Q (35%), p.R969Q (12%), c.2530delA (7%), p.L936X (7%), p.Q289X (7%), and p.I1148T (3%). We also present here a detailed phenotypic assessment for patients whose molecular result was previously reported. Thirty cases were homozygous for 9 different mutations, 13 of which were homozygous for p.H1069Q, and 7 for p.R969Q. Mutations p.H1069Q and p.R969Q appeared to confer a milder disease as patients showed disease onset at a later age, and were associated with milder severity when found in trans with severe mutations. Predicted nonsense and frameshift mutations were associated with severe phenotypic expression with earlier disease onset and lower ceruloplasmin values. WND can be treated by copper-chelation therapy, particularly if the disease is diagnosed before irreversible tissue damage occurs. Our results on the effect of predicted nonsense and frameshift mutations are especially important for early medical intervention in presymptomatic infants and children with these genotypes.
威尔逊病(WND)由ATP7B基因突变引起,具有显著的等位基因异质性。在本研究中,我们报告了20个此前未描述过的WND家系的分子分析结果。将这些结果与我们之前的结果相结合,该队列包括来自69个无关家系的93名索引患者。20种不同的突变占WND染色体的86%。最常见的是p.H1069Q(35%)、p.R969Q(12%)、c.2530delA(7%)、p.L936X(7%)、p.Q289X(7%)和p.I1148T(3%)。我们还在此展示了对分子结果此前已报告的患者的详细表型评估。30例患者为9种不同突变的纯合子,其中13例为p.H1069Q纯合子,7例为p.R969Q纯合子。p.H1069Q和p.R969Q突变似乎导致疾病较轻,因为患者发病年龄较晚,并且当与严重突变处于反式时,病情严重程度较轻。预测的无义突变和移码突变与严重的表型表达相关,发病较早且血浆铜蓝蛋白值较低。WND可通过铜螯合疗法治疗,尤其是在不可逆组织损伤发生之前诊断出疾病的情况下。我们关于预测的无义突变和移码突变影响的结果对于对具有这些基因型的无症状婴儿和儿童进行早期医学干预尤为重要。